miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.
Dos Santos MCT, Barreto-Sanz MA, Correia BRS, Bell R, Widnall C, Perez LT, Berteau C, Schulte C, Scheller D, Berg D, Maetzler W, Galante PAF, Nogueira da Costa A.
Dos Santos MCT, et al. Among authors: galante paf.
Oncotarget. 2018 Apr 3;9(25):17455-17465. doi: 10.18632/oncotarget.24736. eCollection 2018 Apr 3.
Oncotarget. 2018.
PMID: 29707120
Free PMC article.